EUVIMEDEUVIMED entdecken
Open Access

Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice

Renee Fisher, Michael W Epperly, Lora H Rigatti, Donna Shields, Joel S Greenberger, Anthony Green, Amitava Mukherjee

In Vivo · 2024

DOI: 10.21873/invivo.13734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Renee Fisher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A. Hauptthemen laut MEDLINE: Fanconi Anemia, Fanconi Anemia Complementation Group D2 Protein, Fanconi Anemia Complementation Group G Protein, Methylcholanthrene. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Radiation oncologists are reluctant to treat cancer in Fanconi Anemia (FA) patients due to their lack of homologous recombination repair of DNA strand breaks in normal tissues. To determine the therapeutic effects of irradiation and combination chemotherapy on cancer in syngeneic, radiosensitive FA mice, we derived transplantable cancers of the same genotype in three FA mouse strains. MATERIALS AND METHODS: Fancd2-/- mice on a C57BL/6 or Sv/129 background and Fancg-/- mice (C57BL/6 background) that received 3-methylcholanthrene (3-MCA), were monitored for the development of subcutaneous tumors. RESULTS: Tumors were induced at the site of 3-MCA injection, and tumor cell lines were established and found to be transplantable. Explanted tumors were identified as pleomorphic/rhabdomyosarcomas using immunohistochemical biomarkers. CONCLUSION: These transplantable FA mouse tumor cell lines should be valuable for testing effects of new radiation therapy protocols including FLASH high dose rate radiation delivery, immunotherapies, and combined radiation and chemotherapy treatments for radiosensitive FA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fanconi AnemiaFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group G ProteinMethylcholanthreneMice, KnockoutRhabdomyosarcomaAnimalsHumansMiceCarcinogensCell Line, TumorDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

3-methylcholanthreneFanconi anemia mouse modelschemical carcinogen

Substanzen

CarcinogensFancd2 protein, mouseFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group G ProteinMethylcholanthrene

Autor:innen und Institutionen

  • Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
  • Department of DLAR-Veterinary Services, University of Pittsburgh, Pittsburgh, PA, U.S.A.
  • Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A. greenbergerjs@upmc.edu.
  • Department of Pathology, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Förderung

  • NCI NIH HHS

Zitieren

APA

Fisher, R., Epperly, M. W., Rigatti, L. H., Shields, D., Greenberger, J. S., Green, A., & Mukherjee, A. (2024). Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice. In Vivo. https://doi.org/10.21873/invivo.13734

Vancouver

Fisher R, Epperly MW, Rigatti LH, Shields D, Greenberger JS, Green A, et al. Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice. In Vivo. 2024. doi:10.21873/invivo.13734

BibTeX
@article{Fisher2024,
  author = {Fisher, Renee and Epperly, Michael W and Rigatti, Lora H and Shields, Donna and Greenberger, Joel S and Green, Anthony and Mukherjee, Amitava},
  title = {Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2−/−, Fancg−/− (C57BL/6), Fancd2−/− (129/Sv) Mice},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13734}
}
Kostenlos starten →